Altogether, our findings demonstrate that GPR92, a GPCR expressed in IMs and highly modulated by a HFD, controls the chronic inflammatory pathways that drive the pathogenesis of obesity-related diabetes. This evidence concerns the gene LPAR5 and Obesity.